Q2 2021 Getinge AB Earnings Call Transcript
Hello, and welcome to the Getinge AB Audiocast on teleconference Q2 2021. (Operator Instructions) Just to remind you, this conference call is being recorded. I'll now hand the floor to Mattias Perjos, CEO. Please begin, sir.
Thank you very much. With me on today's call, I have Lars Sandstrom, our CFO, who will take you through the financials a little bit later. Let's start with moving over to Page #2 right away and look at the key takeaways from the second quarter of 2021.
Organic net sales growth was 3.6% for the quarter. It's mainly explained by a tail of demand for (inaudible) related to COVID-19 in India. In combination with continued strong development in hemotherapy products is Life Science business area and a comeback in cardiovascular devices. Order intake decreased organically by 6.1% compared to 2020, when we had an exception of COVID-19 related order intake, especially in ventilators. We had a favorable product mix and continuous productivity improvements, and this resulted in higher
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |